Associate Scientist, In Vitro Cancer Biology, at Unum Therapeutics
This is an outstanding opportunity to be a core scientist and scientific leader in a well-funded, early stage biotechnology company on the cutting edge of novel cancer treatments.
Who are we seeking?
BS with at least 3 years or MS with at least 1 year of relevant experience in an industry (preferred) or academic setting.
Experience working on cancer biology projects, ideally in a therapeutic setting.
Experience developing cell-based assays and characterizing mammalian cells with different analysis strategies (e.g. flow cytometry, ELISA, PCR, western blot).
Experience validating tumor antigens for biotherapeutics is a plus.
Outstanding written and oral communication skills, and ability to work in a collaborative setting.
What will you be doing?
Contributing to the characterization of oncology targets through the development of cell-based assays using primary cells and cell lines.
Contributing to the validation of oncology targets by characterizing primary cells and cell lines using a variety of assays (e.g. expression, signaling, proliferation) and analysis methodologies (e.g. qPCR, western blot, flow cytometry, ELISA).
Contributing to drug discovery and technology development projects through collaboration across scientific groups at Unum.
Contributing to other initiatives as they arise in our fast paced start-up environment.
What benefits does Unum offer?
To attract the very best talent, we are offering an extremely generous package that includes competitive pay, a performance-based bonus, stock options, health insurance coverage, trust-based time off, and commuter/parking benefits. Relocation assistance is also available to candidates who live outside of the Boston area.
Unum is an equal opportunity employer.
We are only accepting applications from candidates with authorization to work in the United States at this time.
Note to agencies – we are not accepting unsolicited resumes from agencies and will not be responsible for fees associated with any such submittals.